Our Services
End-to-end Drug Discovery and Development solutions designed to accelerate innovation and drive growth, from bench to market.
Strategic Solutions for Start-ups, CROs, Academic and growing Pharma, empowering progress from discovery through commercialization.
Consultation Services
Empowering your growth with tailored, high-quality strategic solutions
-
R&D-as-a-Service (RaaS): Offer tailored, preclinical-to-clinical solutions, with flexible models.​
​
-
Pipeline/Portfolio Optimization: Enhance asset and portfolio value through indication repurposing, therapeutic area expansion and prioritization frameworks.
​
-
Regulatory Strategy: Guide regulatory submissions, compliance, and site preparedness to ensure smooth progression to clinical trials.
​
-
Partnership and Licensing Support: Assist in structuring and evaluating in-licensing and out-licensing opportunities, while enabling collaborations that accelerate growth and market positioning.
Precision Discovery Services
Specialized solutions for high-impact discovery and development decisions
-
Surface Plasmon Resonance Services
-
Exposure–response interpreted in the context of target biology
-
Kinetics linked to mechanism-relevant compartments and timing
-
Modality-specific considerations (e.g., durability, reversibility, tissue distribution)
-
Translation of nonclinical kinetics to anticipated human behavior
-
-
​Translational & Biomarker Platforms
-
Tools and models that connect target modulation to biological response
-
Integration of pharmacodynamic markers and early translatability signals
-
​​
-
​Connect with us for specialized research solutions.
Integrated Drug Discovery
Your trusted R&D partner, delivering high-quality, niche drug discovery
-
Innovation Assessment & Acceleration: Evaluate and advance promising scientific breakthroughs, from target identification till candidate nomination.
​
-
Support for Early Innovators: Provide scientific and regulatory guidance to help startups and researchers progress toward the clinic, including IND-enabling studies
​
-
Clinical Strategy & Execution: Design and implement clinical strategies with expertise in protocol development, biomarker planning, and site support.
​
-
Collaborative Partnerships: Work jointly with CROs, academic groups, and early-stage biotechs to co-develop and deliver impactful drug discovery programs.